Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development

International Archives of Allergy and Immunology

Volumn 144, Issue 2, 2007, Pages 123-127

  Xiao, Jin Zhong ^a,c   Kondo, Shizuki ^a   Takahashi, Noritoshi ^a   Odamaki, Toshitaka ^a   Iwabuchi, Noriyuki ^a   Miyaji, Kazuhiro ^a   Iwatsuki, Keiji ^a   Enomoto, Tadao ^b  

^a Food Research and Development Laboratory   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

^c MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Allergy; Japanese cedar pollinosis; Thymus and activation regulated chemokine

Indexed keywords

PLACEBO; PROBIOTIC AGENT; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; BIFIDOBACTERIUM LONGUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; JAPANESE; JAPANESE CEDAR; JAPANESE CEDAR POLLINOSIS; MALE; POLLEN ALLERGY; PRIORITY JOURNAL; SEASONAL VARIATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; CHEMOKINES, CC; CRYPTOMERIA; FEMALE; HUMANS; MALE; MIDDLE AGED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX;

EID: 34548682787     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103223     Document Type: Article

References (20)

1. Enomoto T: Reevaluation of hygiene theory. Arerugi 2004;53:465-468.
2. Kidd P: Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8:223-246.
3. Xiao JZ, Kondo S, Yanagisawa N, et al: Effect of probiotic Bifidobacterium longum BB536 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season, a randomized, double-blind, placebo-controlled trial. J Invest Allergol Clin Immunol 2006;16:86-93.
4. Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Miyaji K, Iwatsuki K, Togashi H, Enomoto K, Enomoto T: Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy 2006;36:1325-1335.
5. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A: Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005;60:685-688.
6. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E: Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334-340.
7. Song TW, Sohn MH, Kim ES, Kim KW, Kim KE: Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis. Clin Exp Allergy 2006;36:346-351.
8. Ritter M, Goggel R, Chaudhary N, Wiedenmann A, Jung B, Weith A, Seither P: Elevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammation. Biochem Biophys Res Commun 2005;334:254-262.
9. Okamoto H, Kamatani N: Plasma concentration of TARC/CCL17 is elevated in nonepisodic angioedema associated with eosinophilia. Allergy 2005;60:1091-1092.
10. Tahan F, Karaaslan C, Aslan A, Kiper N, Kalayci O: The role of chemokines in exercise-induced bronchoconstriction in asthma. Ann Allergy Asthma Immunol 2006;96:819-825.
11. Sugawara N, Yamashita T, Ote Y, Miura M, Terada N, Kurosawa M: TARC in allergic disease. Allergy 2002;57:180-181.
12. Takeuchi H, Yamamoto Y, Kitano H, Enomoto T: Changes in thymus- and activation-regulated chemokine (TARC) associated with allergen immunotherapy in patients with perennial allergic rhinitis. J Investig Allergol Clin Immunol 2005;15:172-176.
13. Terada N, Nomura T, Kim WJ, Otsuka Y, Takahashi R, Kishi H, Yamashita T, Sugawara N, Fukuda S, Ikeda-Ito T, Konno A: Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines. Clin Exp Allergy 2001;31:1923-1931.
14. Nomura T, Terada N, Kim WJ, Nakano K, Fukuda Y, Wakita A, Numata T, Konno A: Interleukin-13 induces thymus and activation-regulated chemokine (CCL17) in human peripheral blood mononuclear cells. Cytokine 2002;20:49-55.
15. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O: Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996;271:21514-21521.
16. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O: Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999;11:81-88.
17. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O: The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997;272:15036-15042.
18. Locati M, Bonecchi R, Corsi MM: Chemokines and their receptors: roles in specific clinical conditions and measurement in the clinical laboratory. Am J Clin Pathol 2005;123:S82-S95.
19. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
20. Ogawa T, Hashikawa S, Asai Y, Sakamoto H, Yasuda K, Makimura Y: A new synbiotic, Lactobacillus casei subsp. casei together with dextran, reduces murine and human allergic reaction. FEMS Immunol Med Microbiol 2006;46:400-409.